Sakar Healthcare Limited has informed the Exchange regarding Appointment of Ms Reeya Kothari as Independent Director of the company w.e.f. July 25, 2025 subject to approval of members/shareholders of the Company.
SAKAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sakar Healthcare's board, meeting on July 25, 2025, approved the unaudited financial results for Q1 FY26 (quarter ended June 30, 2025) and fixed September 23, 2025 as the date for the 21st AGM, to be held via video conferencing. Three new Independent Directors were appointed for five-year terms subject to shareholder approval: Ms. Megha Samdani, Ms. Reeya Kothari, and Ms. Hiral Patel. The board also appointed a new Secretarial Auditor (M/s. Nishant Pandya & Associates) for FY 2025-26 to FY 2029-30 and re-appointed the Cost Auditor (M/s. Dalwadi & Associates) for FY 2025-26. Additionally, three senior management personnel were hired: Mr. Sudhir Ghule as COO, Mr. Raviraj Karia as SVP (Finance & Accounts), and Mr. Nimesh Suthar as SVP (International Business), all effective July 25, 2025.
The appointments broaden the board with three independent directors and strengthen the leadership team across operations, finance, and international business, which could support future growth and governance. Routine in nature with no negative signals such as resignations or governance flags.